Skip to content

Clinical trials

Phase 2 trials in Tunisia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Country / region: Tunisia Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20053
20061
20073
20081
20091
20112
20142
20153
20161
20187
20193
20204
20211
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated4
Recruiting3
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Monastir7
Sanofi4
Boehringer Ingelheim3
GlaxoSmithKline3
Novartis Pharmaceuticals3
U.S. Army Medical Research and Development Command3
Cardurion Pharmaceuticals, Inc.2
Protagonist Therapeutics, Inc.2
Abderrahmane Mami Hospital1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms5
Renal Colic4
Leishmaniasis, Cutaneous3
Psoriasis3
Acute Pain2
Head and Neck Neoplasms2
Inflammatory Breast Neoplasms2
Nasopharyngeal Carcinoma2
Nasopharyngeal Neoplasms2
Recurrence2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.